E-LIB Suche - Ergebnisse für: Gerber, M.

1

Bothersome symptoms at midlife in relation to body fat perc..:

Gerber, L. M. ; Whitcomb, B. W. ; Verjee, M. A..
American Journal of Human Biology. 36 (2024) 6 - p. , 2024

2

Autonomic dysfunction and exercise intolerance in post-COVI..:

Schwendinger, F. ; Looser, V.N. ; Gerber, M..
International Journal of Clinical and Health Psychology. 24 (2024) 1 - p. 100429 , 2024

Link: https://doi.org/10.1016/..

3

P227 MANATEE: GYM329 (RO7204239) in combination with Risdip..:

Duong, T. ; Darras, B. ; Morrow, J....
Neuromuscular Disorders. 33 (2023) - p. S92 , 2023

Link: https://doi.org/10.1016/..

4

Universal robust regression via maximum mean discrepancy:

Alquier, P ; Gerber, M
Biometrika. 111 (2023) 1 - p. 71-92 , 2023

Link: https://doi.org/10.1093/..

5

P212 RAINBOWFISH: Primary efficacy and safety data in risdi..:

Finkel, R. ; Farrar, M. ; Servais, L....
Neuromuscular Disorders. 33 (2023) - p. S87-S88 , 2023

Link: https://doi.org/10.1016/..

6

C.2 SUNFISH parts 1 and 2: 4-year efficacy and safety data ..:

Mah, JK ; Oskoui, M ; Day, JW...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 50 (2023) s2 - p. S51-S52 , 2023

Link: https://doi.org/10.1017/..

7

Acta Biologica et Medica Germanica

Band 18, Heft 2 Acta Biologica et Medica Germanica ; Band 18, Heft 2

Bartsch, P. ; Baumann, R. ; Bekemeier, H.... - Reprint 2022 . , [2022]

Link: https://doi.org/10.1515/..

8

FP.24 RAINBOWFISH: Preliminary efficacy and safety data in ..:

Finkel, R. ; Farrar, M. ; Vlodavets, D....
Neuromuscular Disorders. 32 (2022) - p. S85-S86 , 2022

Link: https://doi.org/10.1016/..

9

Toxicity and physicochemical parameters of composts includi..:

Martins, G.A. ; Corrêa, L.B. ; Guidoni, L.L.C....
Waste Management. 138 (2022) - p. 75-82 , 2022

Link: https://doi.org/10.1016/..

10

P.109 FIREFISH Parts 1 and 2: 36-month safety and efficacy ..:

Servais, L. ; Baranello, G. ; Boespflug-Tanguy, O....
Neuromuscular Disorders. 32 (2022) - p. S88 , 2022

Link: https://doi.org/10.1016/..

11

P.110 JEWELFISH: 24-month safety and pharmacodynamic data i..:

Chiriboga, C. ; Bruno, C. ; Duong, T....
Neuromuscular Disorders. 32 (2022) - p. S88 , 2022

Link: https://doi.org/10.1016/..

12

P.114 SUNFISH parts 1 and 2: 3-year efficacy and safety of ..:

Day, J. ; Deconinck, N. ; Mazzone, E....
Neuromuscular Disorders. 32 (2022) - p. S89-S90 , 2022

Link: https://doi.org/10.1016/..

13

SMA - TREATMENT:

Nascimento, A. ; Day, J. ; Deconinck, N....
Neuromuscular Disorders. 31 (2021) - p. S136 , 2021

Link: https://doi.org/10.1016/..

14

CLINICAL TRIAL HIGHLIGHTS:

Servais, L. ; Al-Muhaizea, M. ; Farrar, M....
Neuromuscular Disorders. 31 (2021) - p. S48 , 2021

Link: https://doi.org/10.1016/..

15

A global stochastic optimization particle filter algorithm:

Gerber, M ; Douc, R
Biometrika. 109 (2021) 4 - p. 937-955 , 2021

Link: https://doi.org/10.1093/..